Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs Tetrabenazine (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- Acronyms TETRA-HD
- Sponsors Prestwick Pharmaceuticals
- 05 Nov 2010 New trial record.